NCT07769346 The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
| NCT ID | NCT07769346 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Appendix Cancer Pseudomyxoma Peritonei Research Foundation |
| Condition | Appendix Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2026-02-02 |
| Primary Completion | 2030-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2026-02-02 with a primary completion date of 2030-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ACPMP's first-ever patient-powered global patient registry/natural history study collects patient and caregiver information and data to fuel clinical trials and drive breakthroughs for appendix cancer and PMP. We've invested the time and resources to make our Registry regulatory grade. Our Registry operates under active, ongoing Institutional Review Board (IRB) oversight by independent ethicists. It is powered by NORD's IAMRARE®, an industry gold standard platform built to be consistent with FDA's best thinking on natural history studies.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of appendix cancer. * Meets the study inclusion criteria for participation. * Participant or, when applicable, a legally authorized representative (LAR) is able to provide informed consent and enter information into the Registry. * A designated representative may provide retrospective information for an individual who died from appendix cancer, as permitted by the study protocol. Exclusion Criteria: * Individuals who do not meet the study inclusion criteria. * Individuals for whom required informed consent cannot be obtained.
Contact & Investigator
Deborah Shelton
PRINCIPAL INVESTIGATOR
ACPMP
Frequently Asked Questions
Who can join the NCT07769346 clinical trial?
This trial is open to participants of all sexes, studying Appendix Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07769346 currently recruiting?
Yes, NCT07769346 is actively recruiting participants. Contact the research team at patientregistry@acpmp.org for enrollment information.
Where is the NCT07769346 trial being conducted?
This trial is being conducted at Springfield, United States.
Who is sponsoring the NCT07769346 clinical trial?
NCT07769346 is sponsored by Appendix Cancer Pseudomyxoma Peritonei Research Foundation. The principal investigator is Deborah Shelton at ACPMP. The trial plans to enroll 10,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.